Jpmorgan Chase & CO HALOZYME THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

10,504,000

Previous 7,743,000 35.66%

Previous $0 NaN%

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	N/A	2,761,000 Added 35.66%	10,504,000 $0
Q4 2024 Feb 12, 2025	BUY	N/A	1,696,000 Added 28.05%	7,743,000 $0
Q3 2024 Dec 26, 2024	BUY	N/A	487,000 Added 8.76%	6,047,000 $0
Q3 2024 Nov 08, 2024	BUY	N/A	487,000 Added 8.76%	6,047,000 $0
Q2 2024 Dec 26, 2024	SELL	N/A	-487,000 Reduced 8.05%	5,560,000 $0
Q2 2024 Aug 12, 2024	SELL	N/A	-4,632,000 Reduced 45.45%	5,560,000 $0
Q1 2024 Dec 26, 2024	BUY	N/A	4,145,000 Added 68.55%	10,192,000 $0
Q1 2024 May 10, 2024	BUY	N/A	758,000 Added 8.03%	10,192,000 $0
Q4 2023 Dec 26, 2024	BUY	N/A	3,387,000 Added 56.01%	9,434,000 $0
Q4 2023 Feb 12, 2024	SELL	N/A	-1,935,000 Reduced 17.02%	9,434,000 $0
Q3 2023 Nov 14, 2023	SELL	N/A	-4,578,000 Reduced 28.71%	11,369,000 $0
Q2 2023 Aug 11, 2023	BUY	N/A	670,000 Added 4.39%	15,947,000 $0
Q1 2023 May 11, 2023	BUY	N/A	3,518,000 Added 29.92%	15,277,000 $0
Q4 2022 Feb 13, 2023	BUY	N/A	2,186,000 Added 22.84%	11,759,000 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	N/A	893,000 Added 10.29%	9,573,000 $8.16 Million
Q1 2022 May 11, 2022	BUY	N/A	8,680,000 New	8,680,000 $7.67 Million

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.